E. Manenti

689 total citations
10 papers, 544 citations indexed

About

E. Manenti is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, E. Manenti has authored 10 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 7 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in E. Manenti's work include Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). E. Manenti is often cited by papers focused on Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). E. Manenti collaborates with scholars based in Italy and Belgium. E. Manenti's co-authors include Pietro Lampertico, Massimo Iavarone, Mauro Viganò, M. Colombo, G. Lunghi, Erwin Sablon, Massimo Colombo, E. Arosio, Francesco Bertolini and Angelo Sangiovanni and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

E. Manenti

10 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Manenti Italy	6	517	503	85	29	21	10	544
V. Romagnoli Italy	8	483 0.9×	523 1.0×	30 0.4×	34 1.2×	35 1.7×	17	566
B. Cherubini Italy	6	554 1.1×	601 1.2×	29 0.3×	31 1.1×	36 1.7×	10	624
C.-M. Lee Taiwan	10	365 0.7×	364 0.7×	25 0.3×	12 0.4×	16 0.8×	13	407
S. Xiong China	7	585 1.1×	606 1.2×	144 1.7×	18 0.6×	3 0.1×	15	635
Anna Maria Maina Italy	6	466 0.9×	478 1.0×	38 0.4×	13 0.4×	11 0.5×	8	512
Zunaira Awan Pakistan	10	277 0.5×	261 0.5×	49 0.6×	39 1.3×	6 0.3×	15	343
Taotao Yan China	11	190 0.4×	247 0.5×	42 0.5×	36 1.2×	12 0.6×	31	298
Rie Mineta Japan	11	403 0.8×	381 0.8×	96 1.1×	21 0.7×	3 0.1×	17	428
Li–Yu Wang Taiwan	4	404 0.8×	424 0.8×	16 0.2×	23 0.8×	10 0.5×	6	456

Countries citing papers authored by E. Manenti

Since Specialization

Citations

This map shows the geographic impact of E. Manenti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Manenti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Manenti more than expected).

Fields of papers citing papers by E. Manenti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Manenti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Manenti. The network helps show where E. Manenti may publish in the future.

Co-authorship network of co-authors of E. Manenti

This figure shows the co-authorship network connecting the top 25 collaborators of E. Manenti. A scholar is included among the top collaborators of E. Manenti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Manenti. E. Manenti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Lampertico, Pietro, Mauro Viganò, E. Manenti, Massimo Iavarone, & Massimo Colombo. (2008). 696 ADD ON ADEFOVIR PREVENTS THE EMERGENCE OF ADV RESISTANCE IN LAMIVUDINE-RESISTANT PATIENTS: A 4-YEAR STUDY. Journal of Hepatology. 48. S259–S259. 5 indexed citations

Lampertico, Pietro, Mauro Viganò, E. Manenti, et al.. (2007). Low Resistance to Adefovir Combined With Lamivudine: A 3-Year Study of 145 Lamivudine-Resistant Hepatitis B Patients. Gastroenterology. 133(5). 1445–1451. 246 indexed citations

Lampertico, Pietro, Mauro Viganò, E. Manenti, et al.. (2007). [57] 3 YEARS OF ADEFOVIR AND LAMIVUDINE COMBINATION THERAPY MINIMIZES THE RISK OF GENOTYPIC RESISTANCE TO ADV IN LAM RESISTANT PATIENTS. Journal of Hepatology. 46. S27–S27. 3 indexed citations

Iavarone, Massimo, Pietro Lampertico, Francesca Iannuzzi, et al.. (2006). Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma. Journal of Viral Hepatitis. 14(2). 133–139. 42 indexed citations

Lampertico, Pietro, et al.. (2006). 499 No evidence for ADV resistance in HBeAg-negative lamivudine resistant patients treated with lamivudine-adefovir combination for 3 years. Journal of Hepatology. 44. S186–S186. 1 indexed citations

Lampertico, Pietro, Mauro Viganò, Massimo Iavarone, et al.. (2006). Low rates of genotypic resistance to adefovir in lamivudine resistant patients treated with adefovir-lamivudine combination therapy for 3 years. 44. 5 indexed citations

Lampertico, Pietro, Mauro Viganò, E. Manenti, et al.. (2006). 85 Five years of sequential LAM TO LAM+ADV therapy suppresses HBV replication in most HBeAg-negative cirrhotics, preventing decompensation but not hepatocellular carcinoma. Journal of Hepatology. 44. S38–S38. 12 indexed citations

Lampertico, Pietro, Mauro Viganò, E. Manenti, et al.. (2005). Adefovir rapidly suppresses hepatitis B in HBeAg‐negative patients developing genotypic resistance to lamivudine†. Hepatology. 42(6). 1414–1419. 217 indexed citations

Lampertico, Pietro, et al.. (2005). Five years of sequential lam to lam_adv therapy suppresses HBV replication in most hbeag-negative cirrhotics, preventing decompensation but not hepatocellular carcinoma. 42. 2 indexed citations

10.

Viganò, Mauro, Massimo Colombo, A. Aroldi, et al.. (2005). Long-Term Lamivudine Monotherapy in Renal-Transplant Recipients with Hepatitis-B-Related Cirrhosis. Antiviral Therapy. 10(6). 709–713. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact